Curaleaf International operates extensive cultivation and processing facilities covering over 30,000 m2 in Canada and Portugal, where it grows and processes pharmaceutical-grade cannabis products that undergo third-party testing. The company manufactures and distributes EU GMP-certified medical products to clinics and pharmacies worldwide, with established distribution to over 15 countries including Europe, Australia and New Zealand. In the UK, it provides a pathway from prescription to delivery through its GPhC-registered pharmacy and specialist clinic.
The company partners with leading institutions including Imperial College London and University of Pennsylvania for clinical research into cannabis-based medicine. It operates medical cannabis clinics across multiple regions and an online pharmacy service, positioning itself as a bridge between healthcare professionals and patients who may benefit from medical cannabis.
This is the employer describing itself, in its own words. We do not rate or review employers, and nothing here is our opinion of one.